A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol
一项评估异体iPSC衍生iNKT细胞联合α-GalCer脉冲自体DC治疗复发性和晚期头颈癌患者的耐受性和安全性的I期临床试验:研究方案
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0342387
Kurokawa, Tomoya; Iinuma, Tomohisa; Ebisu, Haruna; Yanagidaira, Tomoha; Inaba, Yosuke; Fujiwara, Tadami; Hattori, Yoko; Fukazawa, Tominaga; Aoki, Takahiro; Koseki, Haruhiko; Hanaoka, Hideki; Hanazawa, Toyoyuki; Motohashi, Shinichiro
肿瘤
T细胞
肿瘤免疫
T细胞
头颈癌
细胞生物学
免疫/内分泌